Schisandrin Inhibits NLRP1 Inflammasome-Mediated Neuronal Pyroptosis in Mouse Models of Alzheimer’s Disease

Schisandrin Inhibits NLRP1 Inflammasome-Mediated Neuronal Pyroptosis in Mouse Models of Alzheimer’s Disease

Quan Li,1 Qi Wang,2 Huibo Guan,3 Yanyan Zhou,2 Li Liu4 1Department of Organs, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin 150040, Heilongjiang, People’s Republic of China; 2Teaching and Research Department of Basic Theory of Traditional Chinese Medicine,...

Full description

Bibliographic Details
Main Authors:	Li Q, Wang Q, Guan H, Zhou Y, Liu L
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-01-01
Series:	Neuropsychiatric Disease and Treatment
Subjects:	alzheimer’s disease pyroptosis schisandrin apoptosis traditional chinese medicine
Online Access:	https://www.dovepress.com/schisandrin-inhibits-nlrp1-inflammasome-mediated-neuronal-pyroptosis-i-peer-reviewed-article-NDT

Similar Items

Bushen Huoxue Acupuncture Inhibits NLRP1 Inflammasome-Mediated Neuronal Pyroptosis in SAMP8 Mouse Model of Alzheimer’s Disease
by: Zhang T, et al.
Published: (2021-02-01)

Combined with UPLC-Triple-TOF/MS-based plasma lipidomics and molecular pharmacology reveals the mechanisms of schisandrin against Alzheimer’s disease
by: Tian-tian Zhao, et al.
Published: (2023-02-01)

Salidroside Ameliorates Alzheimer's Disease by Targeting NLRP3 Inflammasome-Mediated Pyroptosis
by: Yawen Cai, et al.
Published: (2022-01-01)

The role of NLRP3 inflammasome-mediated pyroptosis in ischemic stroke and the intervention of traditional Chinese medicine
by: Jia-Xin Long, et al.
Published: (2023-04-01)

Schisandrin B Induces Apoptosis and Cell Cycle Arrest of Gallbladder Cancer Cells
by: Shan-Shan Xiang, et al.
Published: (2014-08-01)

Schisandrin B Attenuates Hepatic Stellate Cell Activation and Promotes Apoptosis to Protect against Liver Fibrosis
by: Zhiman Li, et al.
Published: (2021-11-01)

Novel discovery of schisandrin A regulating the interplay of autophagy and apoptosis in oligoasthenospermia by targeting SCF/c-kit and TRPV1 via biosensors
by: Lijuan Ma, et al.
Published: (2023-06-01)

The Use of Schisandrin B to Combat Triple-Negative Breast Cancers by Inhibiting NLRP3-Induced Interleukin-1β Production
by: Chun-Ming Chang, et al.
Published: (2024-01-01)

Schisandrin alleviates the cognitive impairment in rats with Alzheimer’s disease by altering the gut microbiota composition to modulate the levels of endogenous metabolites in the plasma, brain, and feces
by: Chengqin Zhang, et al.
Published: (2022-09-01)

Therapeutic effect of Schisandrin A on avian colibacillosis through gut-liver axis
by: Jialu Bao, et al.
Published: (2021-10-01)

Schisandrin protects against ulcerative colitis by inhibiting the SGK1/NLRP3 signaling pathway and reshaping gut microbiota in mice
by: Xiaohu Wang, et al.
Published: (2023-09-01)

In Silico Analysis, Anticonvulsant Activity, and Toxicity Evaluation of Schisandrin B in Zebrafish Larvae and Mice
by: Dorota Nieoczym, et al.
Published: (2023-08-01)

Schisandrin B Inhibits Osteoclastogenesis and Protects Against Ovariectomy-Induced Bone Loss
by: Jia Wang, et al.
Published: (2020-07-01)

Inhibitory effect of Schisandrin on the pharmacokinetics of poziotinib in vivo and in vitro by UPLC‐MS/MS
by: Shuanghu Wang, et al.
Published: (2023-05-01)

The Effect of Schisandrin B on the Development of Multiple Sclerosis
by: Mustafa Cakir, et al.
Published: (2019-12-01)

Prevention of the Pro-Aggressive Effects of Ethanol-Intoxicated Mice by Schisandrin B
by: Ho Yin Pekkle Lam, et al.
Published: (2023-04-01)

Supplementation of Schisandrin B in Semen Extender Improves Quality and Oxidation Resistance of Boar Spermatozoa Stored at 4 °C
by: Yunfa Xie, et al.
Published: (2023-02-01)

Aerobic exercise alleviates pyroptosis-related diseases by regulating NLRP3 inflammasome
by: Shujuan Hu, et al.
Published: (2022-09-01)

Schisandrin B Antagonizes Cardiotoxicity Induced by Pirarubicin by Inhibiting Mitochondrial Permeability Transition Pore (mPTP) Opening and Decreasing Cardiomyocyte Apoptosis
by: Hongwei Shi, et al.
Published: (2021-10-01)

Neuroprotection of Emodin by Inhibition of Microglial NLRP3 Inflammasome-Mediated Pyroptosis
by: Wen Jiang, et al.
Published: (2023-03-01)

Ellagic Acid and Schisandrins: Natural Biaryl Polyphenols with Therapeutic Potential to Overcome Multidrug Resistance in Cancer
by: Sabesan Yoganathan, et al.
Published: (2021-02-01)

Schisandrin B Attenuates Diabetic Cardiomyopathy by Targeting MyD88 and Inhibiting MyD88‐Dependent Inflammation
by: Wu Luo, et al.
Published: (2022-11-01)

NLRP3 inflammasome and pyroptosis in cardiovascular diseases and exercise intervention
by: Ping Ding, et al.
Published: (2024-04-01)

NLRP3 inflammasome-induced pyroptosis in digestive system tumors
by: Jiexia Wen, et al.
Published: (2023-04-01)

Does Pyroptosis Play a Role in Inflammasome-Related Disorders?
by: Jiajia Zhang, et al.
Published: (2022-09-01)

The Role of Pyroptosis in Alzheimer's Disease
by: Yanxiu Ju, et al.
Published: (2023-08-01)

Pyroptosis in NLRP3 inflammasome-related atherosclerosis
by: Xiang Zeng, et al.
Published: (2022-10-01)

The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in diabetic retinopathy
by: Xiaoqin Zheng, et al.
Published: (2023-04-01)

Integrated pyroptosis measurement and metabolomics to elucidate the effect and mechanism of tangzhiqing on atherosclerosis
by: Rui Chen, et al.
Published: (2022-09-01)

Protective effects of Schisandrin B against D-GalN-induced cell apoptosis in human hepatocyte (L02) cells via modulating Bcl-2 and Bax
by: Yanwu Hu, et al.
Published: (2021-01-01)

NLRP3 inflammasome activation mediates sleep deprivation-induced pyroptosis in mice
by: Kun Fan, et al.
Published: (2021-07-01)

Systemic inflammasome activation and pyroptosis associate with the progression of amnestic mild cognitive impairment and Alzheimer’s disease
by: Wenjuan Rui, et al.
Published: (2021-12-01)

Ischemic Preconditioning Provides Neuroprotection by Inhibiting NLRP3 Inflammasome Activation and Cell Pyroptosis
by: Li Gao, et al.
Published: (2023-06-01)

Involvement of PI3K/Akt/β-catenin signaling in schisandrin B-mitigated bone deterioration in an experimental rat model of estrogen deficiency
by: Yimin Liang, et al.
Published: (2020-02-01)

Corrigendum: Schisandrin B Antagonizes Cardiotoxicity Induced by Pirarubicin by Inhibiting Mitochondrial Permeability Transition Pore (mPTP) Opening and Decreasing Cardiomyocyte Apoptosis
by: Hongwei Shi, et al.
Published: (2021-11-01)

NLRP3 Inflammasome/Pyroptosis: A Key Driving Force in Diabetic Cardiomyopathy
by: Lixia Zhang, et al.
Published: (2022-09-01)

Pyroptosis executive protein GSDMD as a biomarker for diagnosis and identification of Alzheimer’s disease
by: Heping Shen, et al.
Published: (2021-04-01)

Emerging Role of NLRP3 Inflammasome and Pyroptosis in Liver Transplantation
by: Fernando Lucas-Ruiz, et al.
Published: (2022-11-01)

PANoptosis: A Cell Death Characterized by Pyroptosis, Apoptosis, and Necroptosis
by: Shi C, et al.
Published: (2023-04-01)

Albendazole-Schisandrin B Co-Therapy on <i>Angiostrongylus cantonensis</i>-Induced Meningoencephalitis in Mice
by: Ho Yin Pekkle Lam, et al.
Published: (2020-07-01)